Overview Proxalutamide Treatment for COVID-19 Female Outpatients Status: Active, not recruiting Trial end date: 2021-12-01 Target enrollment: Participant gender: Summary This study is intended to explore the possible protective role of anti-androgens in SARS-CoV-2 infection Phase: Phase 3 Details Lead Sponsor: Applied Biology, Inc.